Deep Learning and Artificial Intelligence in the Design of Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides
Article Sidebar
Main Article Content
Abstract
Background: Hypertension is a major modifiable risk factor for cardiovascular disease (CVD), and angiotensin-converting enzyme (ACE) remains a principal target within the renin-angiotensin-aldosterone system (RAAS). Food-derived ACE inhibitory peptides (ACEiPs) are attractive because of their specificity and generally favorable safety profile, but conventional discovery through protein hydrolysis, fractionation, purification, and repeated activity assays is labor-intensive and samples only a small fraction of the possible sequence space. Scope and approach: Unlike reviews that consider databases, predictive models, generative methods, or structural validation as separate topics, this review organizes these components into an integrated closed-loop workflow. It connects curated ACEiP data, sequence and chemical encodings, machine-learning and deep-learning predictors, de novo generation, structure prediction, docking, molecular dynamics, free-energy estimation, experimental validation, and feedback-guided model refinement. Key findings and conclusions: The analysis shows that database heterogeneity, inconsistent IC50 assay conditions, class imbalance, and sequence redundancy can limit model generalization. For short food-derived peptides, simple composition and physicochemical descriptors remain competitive baselines; protein language models (PLMs) can add contextual information but may be affected by protein-to-peptide domain shift, whereas SMILES and self-referencing embedded strings (SELFIES) are most useful when atom-level connectivity, stereochemistry, or non-canonical residues must be represented. A practical post-screening stage should jointly assess potency, ACE-domain binding, gastrointestinal stability, permeability, solubility, toxicity, allergenicity, and manufacturability. Progress toward translation therefore depends on a closed loop in which experimentally measured activity and developability data update the training set and guide subsequent design cycles.
Article Details
Copyright (c) 2026 Qian Z, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Udenigwe CC, Aluko RE. Food protein-derived bioactive peptides: production, processing, and potential health benefits. J Food Sci 2012;77:R11-24. Available from: https://doi.org/10.1111/j.1750-3841.2011.02455.x. DOI: https://doi.org/10.1111/j.1750-3841.2011.02455.x
2. Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A. Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension. J Renin Angiotensin Aldosterone Syst 2023;2023:7890188. Available from: https://doi.org/10.1155/2023/7890188. DOI: https://doi.org/10.1155/2023/7890188
3. Nielsen SD, Beverly RL, Qu Y, Dallas DC. Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization. Food Chem 2017;232:673–82. Available from: https://doi.org/10.1016/j.foodchem.2017.04.056.
4. Hajfathalian M, Ghelichi S, García-Moreno PJ, Moltke Sørensen A-D, Jacobsen C. Peptides: Production, bioactivity, functionality, and applications. Critical Reviews in Food Science and Nutrition 2018;58:3097–129. Available from: https://doi.org/10.1080/10408398.2017.1352564
5. Papakonstantinou E, Bacopoulou F, Megalooikonomou V, Efthimiadou A, Vlachakis D. An in silico and in vitro pipeline for the rapid screening of helicase modulators. EMBnet J 2020;25:e927. Available from: https://doi.org/10.14806/ej.25.0.927. DOI: https://doi.org/10.14806/ej.25.0.927
6. Dai H, He M, Hu G, Li Z, Al-Romaima A, Wu Z, et al. Discovery of ACE Inhibitory Peptides Derived from Green Coffee Using In Silico and In Vitro Methods. Foods 2023;12:3480. Available from: https://doi.org/10.3390/foods12183480. DOI: https://doi.org/10.3390/foods12183480
7. Purcell D, Packer MA, Hayes M. Identification of Bioactive Peptides from a Laminaria digitata Protein Hydrolysate Using In Silico and In Vitro Methods to Identify Angiotensin-1-Converting Enzyme (ACE-1) Inhibitory Peptides. Mar Drugs 2023;21:90. Available from: https://doi.org/10.3390/md21020090. DOI: https://doi.org/10.3390/md21020090
8. Amigo L, Martínez-Maqueda D, Hernández-Ledesma B. In Silico and In Vitro Analysis of Multifunctionality of Animal Food-Derived Peptides. Foods 2020;9:991. Available from: https://doi.org/10.3390/foods9080991. DOI: https://doi.org/10.3390/foods9080991
9. Minkiewicz P, Iwaniak A, Darewicz M. BIOPEP-UWM Virtual—A Novel Database of Food-Derived Peptides with In Silico-Predicted Biological Activity. Applied Sciences 2022;12. Available from: https://doi.org/10.3390/app12147204. DOI: https://doi.org/10.3390/app12147204
10. Yang W, Wang S, Lee GR, Zhang JZ, Courbet A, Juergens D, et al. The past, present and future of de novo protein design. Nature 2026;652:1139–52. Available from: https://doi.org/10.1038/s41586-026-10328-7. DOI: https://doi.org/10.1038/s41586-026-10328-7
11. Lai L, Liu Y, Song B, Li K, Zeng X. Deep Generative Models for Therapeutic Peptide Discovery: A Comprehensive Review. ACM Comput Surv 2025;57:155:1-155:29. Available from: https://doi.org/10.1145/3714455.
12. Xiang L, Qiu Z, Zhao R, Zheng Z, Qiao X. Advancement and prospects of production, transport, functional activity and structure-activity relationship of food-derived angiotensin converting enzyme (ACE) inhibitory peptides. Crit Rev Food Sci Nutr 2023;63:1437–63. Available from: https://doi.org/10.1080/10408398.2021.1964433. DOI: https://doi.org/10.1080/10408398.2021.1964433
13. Jobe A, Antony P, Altabbal S, Al Dhaheri Y, Vijayan R. Interaction of hemorphins with ACE homologs. Sci Rep 2023;13:3743. Available from: https://doi.org/10.1038/s41598-023-30771-0. DOI: https://doi.org/10.1038/s41598-023-30771-0
14. Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors | Clinical Science | Portland Press n.d. Available from: https://portlandpress.com/clinsci/article/126/4/305/69188/Fragment-based-design-for-the-development-of-N DOI: https://doi.org/10.1042/CS20130403
15. Molecular basis of domain‐specific angiotensin I‐converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat n.d. Available from: https://doi.org/10.1111/febs.70232. DOI: https://doi.org/10.1111/febs.70232
16. Cozier GE, Lubbe L, Sturrock ED, Acharya KR. ACE-domain selectivity extends beyond direct interacting residues at the active site. Biochem J 2020;477:1241–59. Available from: https://doi.org/10.1042/BCJ20200060. DOI: https://doi.org/10.1042/BCJ20200060
17. Structural Requirements of Angiotensin I‐Converting Enzyme Inhibitory Peptides: Quantitative Structure‐Activity Relationship Modeling of Peptides Containing 4‐10 Amino Acid Residues n.d. Available from: https://doi.org/10.1002/qsar.200630005. DOI: https://doi.org/10.1002/qsar.200630005
18. Bank RPD. RCSB PDB - 1O8A: Crystal Structure of Human Angiotensin Converting Enzyme (Native). n.d. Available from: https://www.rcsb.org/structure/1O8A (accessed May 20, 2026).
19. Bank RPD. RCSB PDB - 1UZE: Complex of the anti-hypertensive drug enalaprilat and the human testicular angiotensin I-converting enzyme n.d. Available from: https://www.rcsb.org/structure/1UZE
20. Lai L, Liu Y, Song B, Li K, Zeng X. Deep Generative Models for Therapeutic Peptide Discovery: A Comprehensive Review. ACM Comput Surv 2025;57:155:1-155:29. Available from: https://doi.org/10.1145/3714455. DOI: https://doi.org/10.1145/3714455
21. Hajfathalian M, Ghelichi S, García-Moreno PJ, Moltke Sørensen A-D, Jacobsen C. Peptides: Production, bioactivity, functionality, and applications. Critical Reviews in Food Science and Nutrition 2018;58:3097–129. Available from: https://doi.org/10.1080/10408398.2017.1352564. DOI: https://doi.org/10.1080/10408398.2017.1352564
22. Minkiewicz P, Iwaniak A, Darewicz M. BIOPEP-UWM Database of Bioactive Peptides: Current Opportunities. International Journal of Molecular Sciences 2019;20:5978. Available from: https://doi.org/10.3390/ijms20235978. DOI: https://doi.org/10.3390/ijms20235978
23. Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, et al. AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides. Nucleic Acids Res 2015;43:D956–62. Available from: https://doi.org/10.1093/nar/gku1141.
24. Panyayai T, Ngamphiw C, Tongsima S, Mhuantong W, Limsripraphan W, Choowongkomon K, Sawatdichaikul O. FeptideDB: A web application for new bioactive peptides from food protein. Heliyon 2019;5:e02076. Available from: https://doi.org/10.1016/j.heliyon.2019.e02076. DOI: https://doi.org/10.1016/j.heliyon.2019.e02076
25. Nielsen SD, Beverly RL, Qu Y, Dallas DC. Milk bioactive peptide database: A comprehensive database of milk protein-derived bioactive peptides and novel visualization. Food Chem 2017;232:673–82. Available from: https://doi.org/10.1016/j.foodchem.2017.04.056. DOI: https://doi.org/10.1016/j.foodchem.2017.04.056
26. Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, et al. AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides. Nucleic Acids Res 2015;43:D956–62. Available from: https://doi.org/10.1093/nar/gku1141. DOI: https://doi.org/10.1093/nar/gku1141
27. Chaudhary A, Bhalla S, Patiyal S, Raghava GPS, Sahni G. FermFooDb: A database of bioactive peptides derived from fermented foods. Heliyon 2021;7:e06668. Available from: https://doi.org/10.1016/j.heliyon.2021.e06668. DOI: https://doi.org/10.1016/j.heliyon.2021.e06668
28. Yang S, Ni J, Xu P. AI4ACEIP: A Computing Tool to Identify Food Peptides with High Inhibitory Activity for ACE by Merged Molecular Representation and Rich Intrinsic Sequence Information Based on an Ensemble Learning Strategy. J Agric Food Chem 2024;72:25340–56. Available from: https://doi.org/10.1021/acs.jafc.4c05650. DOI: https://doi.org/10.1021/acs.jafc.4c05650
29. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Journal of Chemical Information and Modeling n.d. Available from: https://pubs.acs.org/doi/10.1021/ci00057a005
30. Gilmer J, Schoenholz SS, Riley PF, Vinyals O, Dahl GE. Neural Message Passing for Quantum Chemistry. Proceedings of the 34th International Conference on Machine Learning, vol. 70, PMLR; 2017, p. 1263–72.
31. Das P, Sercu T, Wadhawan K, Padhi I, Gehrmann S, Cipcigan F, et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat Biomed Eng 2021;5:613–23. Available from: https://doi.org/10.1038/s41551-021-00689-x. DOI: https://doi.org/10.1038/s41551-021-00689-x
32. Amino acid substitution matrices from protein blocks. | PNAS n.d. Available from: https://www.pnas.org/doi/abs/10.1073/pnas.89.22.10915
33. Rao R, Meier J, Sercu T, Ovchinnikov S, Rives A. Transformer protein language models are unsupervised structure learners. bioRxiv 2020:2020.12.15.422761. Available from: https://doi.org/10.1101/2020.12.15.422761. DOI: https://doi.org/10.1101/2020.12.15.422761
34. Rives A, Meier J, Sercu T, Goyal S, Lin Z, Liu J, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc Natl Acad Sci USA 2021;118:e2016239118. Available from: https://doi.org/10.1073/pnas.2016239118. DOI: https://doi.org/10.1073/pnas.2016239118
35. Elnaggar A, Heinzinger M, Dallago C, Rehawi G, Wang Y, Jones L, et al. ProtTrans: Toward Understanding the Language of Life Through Self-Supervised Learning. IEEE Transactions on Pattern Analysis and Machine Intelligence 2022;44:7112–27. Available from: https://doi.org/10.1109/TPAMI.2021.3095381.
36. Bengio Y, Ducharme R, Vincent P, Jauvin C. A Neural Probabilistic Language Model n.d.
37. Asgari E, Mofrad MRK. Continuous Distributed Representation of Biological Sequences for Deep Proteomics and Genomics. PLOS ONE 2015;10:e0141287. Available from: https://doi.org/10.1371/journal.pone.0141287. DOI: https://doi.org/10.1371/journal.pone.0141287
38. Bhasin M, Raghava GPS. Classification of Nuclear Receptors Based on Amino Acid Composition and Dipeptide Composition*. Journal of Biological Chemistry 2004;279:23262–6. Available from: https://doi.org/10.1074/jbc.M401932200. DOI: https://doi.org/10.1074/jbc.M401932200
39. Chou K-C. Prediction of protein cellular attributes using pseudo-amino acid composition. Proteins: Structure, Function, and Bioinformatics 2001;44:60–60. Available from: https://doi.org/10.1002/prot.1072. DOI: https://doi.org/10.1002/prot.1072
40. Amino acid substitution matrices. Advances in Protein Chemistry, vol. 54, Academic Press; 2000, p. 73–97. Available from: https://doi.org/10.1016/S0065-3233(00)54003-0. DOI: https://doi.org/10.1016/S0065-3233(00)54003-0
41. Manavalan B, Basith S, Shin TH, Wei L, Lee G. mAHTPred: a sequence-based meta-predictor for improving the prediction of anti-hypertensive peptides using effective feature representation. Bioinformatics 2019;35:2757–65. Available from: https://doi.org/10.1093/bioinformatics/bty1047. DOI: https://doi.org/10.1093/bioinformatics/bty1047
42. Sandberg M, Eriksson L, Jonsson J, Sjöström M, Wold S. New Chemical Descriptors Relevant for the Design of Biologically Active Peptides. A Multivariate Characterization of 87 Amino Acids. J Med Chem 1998;41:2481–91. Available from: https://doi.org/10.1021/jm9700575. DOI: https://doi.org/10.1021/jm9700575
43. Krenn M, Häse F, Nigam A, Friederich P, Aspuru-Guzik A. Self-referencing embedded strings (SELFIES): A 100% robust molecular string representation. Mach Learn: Sci Technol 2020;1:045024. Available from: https://doi.org/10.1088/2632-2153/aba947. DOI: https://doi.org/10.1088/2632-2153/aba947
44. Lin Z, Akin H, Rao R, Hie B, Zhu Z, Lu W, et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 2023;379:1123–30. Available from: https://doi.org/10.1126/science.ade2574. DOI: https://doi.org/10.1126/science.ade2574
45. Elnaggar A, Heinzinger M, Dallago C, Rehawi G, Wang Y, Jones L, et al.. ProtTrans: Toward Understanding the Language of Life Through Self-Supervised Learning. IEEE Transactions on Pattern Analysis and Machine Intelligence 2022;44:7112–27. Available from: https://doi.org/10.1109/TPAMI.2021.3095381. DOI: https://doi.org/10.1109/TPAMI.2021.3095381
46. Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 1988;28:31–6. Available from: https://doi.org/10.1021/ci00057a005. DOI: https://doi.org/10.1021/ci00057a005
47. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015;521:436–44. Available from: https://doi.org/10.1038/nature14539. DOI: https://doi.org/10.1038/nature14539
48. Xia T, Ku W-S. Geometric Graph Representation Learning on Protein Structure Prediction. Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining, Virtual Event Singapore: ACM; 2021, p. 1873–83. Available from: https://doi.org/10.1145/3447548.3467323. DOI: https://doi.org/10.1145/3447548.3467323
49. Fernández D, Olivera-Nappa Á, Uribe-Paredes R, Medina-Ortiz D. Exploring Machine Learning Algorithms and Protein Language Models Strategies to Develop Enzyme Classification Systems. In: Rojas I, Valenzuela O, Rojas Ruiz F, Herrera LJ, Ortuño F, editors. Bioinformatics and Biomedical Engineering, vol. 13919, Cham: Springer Nature Switzerland; 2023, p. 307–19. Available from: https://doi.org/10.1007/978-3-031-34953-9_24. DOI: https://doi.org/10.7490/f1000research.1119569.1
50. Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 2021;373:871–6. Available from: https://doi.org/10.1126/science.abj8754. DOI: https://doi.org/10.1126/science.abj8754
51. Charoenkwan P, Chumnanpuen P, Schaduangrat N, Shoombuatong W. Deepstack-ACE: A deep stacking-based ensemble learning framework for the accelerated discovery of ACE inhibitory peptides. Methods 2025;234:131–40. Available from: https://doi.org/10.1016/j.ymeth.2024.12.005. DOI: https://doi.org/10.1016/j.ymeth.2024.12.005
52. Du Z, Ding X, Hsu W, Munir A, Xu Y, Li Y. pLM4ACE: A protein language model based predictor for antihypertensive peptide screening. Food Chemistry 2024;431:137162. Available from: https://doi.org/10.1016/j.foodchem.2023.137162. DOI: https://doi.org/10.1016/j.foodchem.2023.137162
53. Khatun MstS, Hasan MdM, Kurata H. PreAIP: Computational Prediction of Anti-inflammatory Peptides by Integrating Multiple Complementary Features. Front Genet 2019;10:129. Available from: https://doi.org/10.3389/fgene.2019.00129. DOI: https://doi.org/10.3389/fgene.2019.00129
54. Sharma R, Shrivastava S, Singh SK, Kumar A, Singh AK, Saxena S. Deep-AVPpred: Artificial Intelligence Driven Discovery of Peptide Drugs for Viral Infections. IEEE J Biomed Health Inform 2022;26:5067–74. Available from: https://doi.org/10.1109/JBHI.2021.3130825. DOI: https://doi.org/10.1109/JBHI.2021.3130825
55. Zhang Y, Lin J, Zhao L, Zeng X, Liu X. A novel antibacterial peptide recognition algorithm based on BERT n.d.
56. Barbero-Aparicio JA, Olivares-Gil A, Rodríguez JJ, García-Osorio C, Díez-Pastor JF. Addressing data scarcity in protein fitness landscape analysis: A study on semi-supervised and deep transfer learning techniques. Information Fusion 2024;102:102035. Available from: https://doi.org/10.1016/j.inffus.2023.102035. DOI: https://doi.org/10.1016/j.inffus.2023.102035
57. Ma Y, Guo Z, Xia B, Zhang Y, Liu X, Yu Y, et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat Biotechnol 2022;40:921–31. Available from: https://doi.org/10.1038/s41587-022-01226-0. DOI: https://doi.org/10.1038/s41587-022-01226-0
58. Wang Y, Li N, Wang X, Cao F, Xiong S, Wei L. Integrating Protein Language Models and Geometric Deep Learning for Peptide Toxicity Prediction. J Chem Inf Model 2025;65:7800–10. Available from: https://doi.org/10.1021/acs.jcim.5c01073. DOI: https://doi.org/10.1021/acs.jcim.5c01073
59. Zou H. iAHTP-LH: Integrating Low-Order and High-Order Correlation Information for Identifying Antihypertensive Peptides. Int J Pept Res Ther 2022;28:106. Available from: https://doi.org/10.1007/s10989-022-10414-0. DOI: https://doi.org/10.1007/s10989-022-10414-0
60. Alley EC, Khimulya G, Biswas S, AlQuraishi M, Church GM. Unified rational protein engineering with sequence-based deep representation learning. Nat Methods 2019;16:1315–22. Available from: https://doi.org/10.1038/s41592-019-0598-1. DOI: https://doi.org/10.1038/s41592-019-0598-1
61. Rao R, Liu J, Verkuil R, Meier J, Canny JF, Abbeel P, et al. MSA Transformer 2021:2021.02.12.430858. Available from: https://doi.org/10.1101/2021.02.12.430858. DOI: https://doi.org/10.1101/2021.02.12.430858
62. Gómez-Bombarelli R, Wei JN, Duvenaud D, Hernández-Lobato JM, Sánchez-Lengeling B, Sheberla D, et al. Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent Sci 2018;4:268–76. Available from: https://doi.org/10.1021/acscentsci.7b00572. DOI: https://doi.org/10.1021/acscentsci.7b00572
63. Ferruz N, Höcker B. Controllable protein design with language models. Nat Mach Intell 2022;4:521–32. Available from: https://doi.org/10.1038/s42256-022-00499-z. DOI: https://doi.org/10.1038/s42256-022-00499-z
64. Madani A, Krause B, Greene ER, Subramanian S, Mohr BP, Holton JM, et al. Large language models generate functional protein sequences across diverse families. Nat Biotechnol 2023;41:1099–106. Available from: https://doi.org/10.1038/s41587-022-01618-2. DOI: https://doi.org/10.1038/s41587-022-01618-2
65. Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, et al. A Deep Learning Approach to Antibiotic Discovery. Cell 2020;181:475–83. Available from: https://doi.org/10.1016/j.cell.2020.04.001.
66. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021;596:583–9. Available from: https://doi.org/10.1038/s41586-021-03819-2. DOI: https://doi.org/10.1038/s41586-021-03819-2
67. Kingma DP, Welling M. Auto-Encoding Variational Bayes 2022. Available from: https://doi.org/10.48550/arXiv.1312.6114.
68. Greener JG, Moffat L, Jones DT. Design of metalloproteins and novel protein folds using variational autoencoders. Sci Rep 2018;8:16189. Available from: https://doi.org/10.1038/s41598-018-34533-1. DOI: https://doi.org/10.1038/s41598-018-34533-1
69. Goodfellow IJ, Pouget-Abadie J, Mirza M, Xu B, Warde-Farley D, Ozair S, Courville A, Bengio Y. Generative Adversarial Networks 2014. Available from: https://doi.org/10.48550/arXiv.1406.2661.
70. Gupta A, Zou J. Feedback GAN for DNA optimizes protein functions. Nat Mach Intell 2019;1:105–11. Available from: https://doi.org/10.1038/s42256-019-0017-4. DOI: https://doi.org/10.1038/s42256-019-0017-4
71. Repecka D, Jauniskis V, Karpus L, Rembeza E, Rokaitis I, Zrimec J, et al. Expanding functional protein sequence spaces using generative adversarial networks. Nat Mach Intell 2021;3:324–33. Available from: https://doi.org/10.1038/s42256-021-00310-5. DOI: https://doi.org/10.1038/s42256-021-00310-5
72. Wan F, Kontogiorgos-Heintz D, Fuente-Nunez C de la. Deep generative models for peptide design. Digital Discovery 2022;1:195–208. Available from: https://doi.org/10.1039/D1DD00024A. DOI: https://doi.org/10.1039/D1DD00024A
73. Ho J, Jain A, Abbeel P. Denoising Diffusion Probabilistic Models. Advances in Neural Information Processing Systems, vol. 33, Curran Associates, Inc.; 2020, p. 6840–51.
74. Dhariwal P, Nichol A. Diffusion Models Beat GANs on Image Synthesis. Advances in Neural Information Processing Systems, vol. 34, Curran Associates, Inc.; 2021, p. 8780–94.
75. Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, et al. De novo design of protein structure and function with RFdiffusion. Nature 2023;620:1089–100. Available from: https://doi.org/10.1038/s41586-023-06415-8. DOI: https://doi.org/10.1038/s41586-023-06415-8
76. Popova M, Isayev O, Tropsha A. Deep reinforcement learning for de novo drug design. Science Advances 2018. Available from: https://doi.org/10.1126/sciadv.aap7885. DOI: https://doi.org/10.1126/sciadv.aap7885
77. Olivecrona M, Blaschke T, Engkvist O, Chen H. Molecular de-novo design through deep reinforcement learning. J Cheminform 2017;9:48. Available from: https://doi.org/10.1186/s13321-017-0235-x. DOI: https://doi.org/10.1186/s13321-017-0235-x
78. Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, et al. A Deep Learning Approach to Antibiotic Discovery. Cell 2020;181:475–83. Available from: https://doi.org/10.1016/j.cell.2020.04.001. DOI: https://doi.org/10.1016/j.cell.2020.04.001
79. Jogi N, Yathisha UG, Bhat I, Mamatha BS. Antihypertensive activity of orally consumed ACE-I inhibitory peptides. Crit Rev Food Sci Nutr 2022;62:8986–99. Available from: https://doi.org/10.1080/10408398.2021.1938508. DOI: https://doi.org/10.1080/10408398.2021.1938508
80. Méndez-Lucio O, Baillif B, Clevert D-A, Rouquié D, Wichard J. De novo generation of hit-like molecules from gene expression signatures using artificial intelligence. Nat Commun 2020;11:10. Available from: https://doi.org/10.1038/s41467-019-13807-w. DOI: https://doi.org/10.1038/s41467-019-13807-w
81. Jin W, Barzilay R, Jaakkola T. Junction Tree Variational Autoencoder for Molecular Graph Generation 2019. Available from: https://doi.org/10.48550/arXiv.1802.04364. DOI: https://doi.org/10.1039/9781788016841-00228
82. Torng W, Altman RB. Graph Convolutional Neural Networks for Predicting Drug-Target Interactions. J Chem Inf Model 2019;59:4131–49. Available from: https://doi.org/10.1021/acs.jcim.9b00628. DOI: https://doi.org/10.1021/acs.jcim.9b00628
83. Strokach A, Becerra D, Corbi-Verge C, Perez-Riba A, Kim PM. Fast and Flexible Protein Design Using Deep Graph Neural Networks. Cels 2020;11:402-411.e4. Available from: https://doi.org/10.1016/j.cels.2020.08.016. DOI: https://doi.org/10.1016/j.cels.2020.08.016
84. Sevgen E, Moller J, Lange A, Parker J, Quigley S, Mayer J, et al. ProT-VAE: Protein Transformer Variational AutoEncoder for functional protein design. Proc Natl Acad Sci U S A 2025;122:e2408737122. Available from: https://doi.org/10.1073/pnas.2408737122. DOI: https://doi.org/10.1073/pnas.2408737122
85. Zhang J, Zhou Y, Zhu T, Zhu Z. PepCCD: A Contrastive Conditioned Diffusion Framework for Target-Specific Peptide Generation n.d.
86. High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design n.d.
87. Wang F, Wang Y, Feng L, Zhang C, Lai L. Target-Specific De Novo Peptide Binder Design with DiffPepBuilder 2024. Available from: https://doi.org/10.48550/arXiv.2405.00128. DOI: https://doi.org/10.1021/acs.jcim.4c00975
88. Li J, Cheng C, Wu Z, Guo R, Luo S, Ren Z, et al. Full-Atom Peptide Design based on Multi-modal Flow Matching 2024. Available from: https://doi.org/10.48550/arXiv.2406.00735.
89. Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention Is All You Need 2023. Available from: https://doi.org/10.48550/arXiv.1706.03762.
90. Ferruz N, Schmidt S, Höcker B. ProtGPT2 is a deep unsupervised language model for protein design. Nat Commun 2022;13:4348. Available from: https://doi.org/10.1038/s41467-022-32007-7. DOI: https://doi.org/10.1038/s41467-022-32007-7
91. Hesslow D, Zanichelli N, Notin P, Poli I, Marks D. RITA: a Study on Scaling Up Generative Protein Sequence Models 2022. Available from: https://doi.org/10.48550/arXiv.2205.05789.
92. Shah A, Guntuboina C, Farimani AB. Peptide-GPT: Generative Design of Peptides using Generative Pre-trained Transformers and Bio-informatic Supervision 2024. Available from: https://doi.org/10.48550/arXiv.2410.19222.
93. Dinh L, Krueger D, Bengio Y. NICE: Non-linear Independent Components Estimation 2015. Available from: https://doi.org/10.48550/arXiv.1410.8516.
94. Dinh L, Sohl-Dickstein J, Bengio S. Density estimation using Real NVP 2017. Available from: https://doi.org/10.48550/arXiv.1605.08803.
95. Papamakarios G, Pavlakou T, Murray I. Masked Autoregressive Flow for Density Estimation 2018. Available from: https://doi.org/10.48550/arXiv.1705.07057.
96. Grathwohl W, Chen RTQ, Bettencourt J, Sutskever I, Duvenaud D. FFJORD: Free-form Continuous Dynamics for Scalable Reversible Generative Models 2018. Available from: https://doi.org/10.48550/arXiv.1810.01367.
97. Hillmer RA. Systems Biology for Biologists. PLoS Pathog 2015;11:e1004786. Available from: https://doi.org/10.1371/journal.ppat.1004786. DOI: https://doi.org/10.1371/journal.ppat.1004786
98. Pinu FR, Beale DJ, Paten AM, Kouremenos K, Swarup S, Schirra HJ, Wishart D. Systems Biology and Multi-Omics Integration: Viewpoints from the Metabolomics Research Community. Metabolites 2019;9:76. Available from: https://doi.org/10.3390/metabo9040076. DOI: https://doi.org/10.3390/metabo9040076
99. Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC. The application of systems biology to drug discovery. Current Opinion in Chemical Biology 2006;10:294–302. Available from: https://doi.org/10.1016/j.cbpa.2006.06.025. DOI: https://doi.org/10.1016/j.cbpa.2006.06.025
100. Jamil IN, Remali J, Azizan KA, Nor Muhammad NA, Arita M, Goh HH, et al. Systematic Multi-Omics Integration (MOI) Approach in Plant Systems Biology. Front Plant Sci 2020;11:944. Available from: https://doi.org/10.3389/fpls.2020.00944. DOI: https://doi.org/10.3389/fpls.2020.00944
101. Sarkar C, Das B, Rawat VS, Wahlang JB, Nongpiur A, Tiewsoh I, et al. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development. Int J Mol Sci 2023;24:2026. Available from: https://doi.org/10.3390/ijms24032026. DOI: https://doi.org/10.3390/ijms24032026
102. Krapp LF, Abriata LA, Cortés Rodriguez F, Dal Peraro M. PeSTo: parameter-free geometric deep learning for accurate prediction of protein binding interfaces. Nat Commun 2023;14:2175. Available from: https://doi.org/10.1038/s41467-023-37701-8. DOI: https://doi.org/10.1038/s41467-023-37701-8
103. Tucs A, Tran DP, Yumoto A, Ito Y, Uzawa T, Tsuda K. Generating Ampicillin-Level Antimicrobial Peptides with Activity-Aware Generative Adversarial Networks. ACS Omega 2020;5:22847–51. Available from: https://doi.org/10.1021/acsomega.0c02088. DOI: https://doi.org/10.1021/acsomega.0c02088
104. Zhang S, Jiang Z, Huang R, Huang W, Peng S, Mo S, et al. PRO‐LDM: A Conditional Latent Diffusion Model for Protein Sequence Design and Functional Optimization. Adv Sci (Weinh) 2025;12:e02723. Available from: https://doi.org/10.1002/advs.202502723. DOI: https://doi.org/10.1002/advs.202502723
105. Jendrusch MA, Yang ALJ, Cacace E, Bobonis J, Voogdt CGP, Kaspar S, et al. AlphaDesign: a de novo protein design framework based on AlphaFold. Mol Syst Biol 2025;21:1166–89. Available from: https://doi.org/10.1038/s44320-025-00119-z. DOI: https://doi.org/10.1038/s44320-025-00119-z
106. Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotechnol Biochem 1994;58:1767–71. Available from: https://doi.org/10.1271/bbb.58.1767. DOI: https://doi.org/10.1271/bbb.58.1767
107. Lammi C, Boschin G, Bartolomei M, Arnoldi A, Galaverna G, Dellafiora L. Mechanistic Insights into Angiotensin I-Converting Enzyme Inhibitory Tripeptides to Decipher the Chemical Basis of Their Activity. J Agric Food Chem 2022;70:11572–8. Available from: https://doi.org/10.1021/acs.jafc.2c04755. DOI: https://doi.org/10.1021/acs.jafc.2c04755
108. Manoharan S, Shuib AS, Abdullah N. Structural Characteristics And Antihypertensive Effects Of Angiotensin-I-Converting Enzyme Inhibitory Peptides In The Renin-Angiotensin And Kallikrein Kinin Systems. Afr J Tradit Complement Altern Med 2017;14:383–406. Available from: https://doi.org/10.21010/ajtcam.v14i2.39. DOI: https://doi.org/10.21010/ajtcam.v14i2.39
109. Liu J, Song W, Gao X, Sun J, Liu C, Fang L, et al. A combined in vitro and in silico study of the inhibitory mechanism of angiotensin-converting enzyme with peanut peptides. Int J Biol Macromol 2024;268:131901. Available from: https://doi.org/10.1016/j.ijbiomac.2024.131901. DOI: https://doi.org/10.1016/j.ijbiomac.2024.131901
110. Escudero E, Mora L, Toldrá F. Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chem 2014;161:305–11. Available from: https://doi.org/10.1016/j.foodchem.2014.03.117. DOI: https://doi.org/10.1016/j.foodchem.2014.03.117
111. Pei J, Gao X, Pan D, Hua Y, He J, Liu Z, et al. Advances in the stability challenges of bioactive peptides and improvement strategies. Curr Res Food Sci 2022;5:2162–70. Available from: https://doi.org/10.1016/j.crfs.2022.10.031. DOI: https://doi.org/10.1016/j.crfs.2022.10.031
112. Hirota T, Nonaka A, Matsushita A, Uchida N, Ohki K, Asakura M, et al. Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart Vessels 2011;26:549–56. Available from: https://doi.org/10.1007/s00380-010-0096-y. DOI: https://doi.org/10.1007/s00380-010-0096-y
113. Ohsawa K, Satsu H, Ohki K, Enjoh M, Takano T, Shimizu M. Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J Agric Food Chem 2008;56:854–8. Available from: https://doi.org/10.1021/jf072671n. DOI: https://doi.org/10.1021/jf072671n
114. Rutella GS, Solieri L, Martini S, Tagliazucchi D. Release of the Antihypertensive Tripeptides Valine-Proline-Proline and Isoleucine-Proline-Proline from Bovine Milk Caseins during in Vitro Gastrointestinal Digestion. J Agric Food Chem 2016;64:8509–15. Available from: https://doi.org/10.1021/acs.jafc.6b03271. DOI: https://doi.org/10.1021/acs.jafc.6b03271
115. Şensu E, Koku H, Demircan E, Şişman S, Gülseren İ, Karaduman T, et al. Nanoliposomal Encapsulation and Purification of Angiotensin-Converting Enzyme Inhibitor Peptides from Ulva rigida. ACS Omega 2025;10:21609–20. Available from: https://doi.org/10.1021/acsomega.5c00780. DOI: https://doi.org/10.1021/acsomega.5c00780
116. Li M, Guo Q, Lin Y, Bao H, Miao S. Recent Progress in Microencapsulation of Active Peptides-Wall Material, Preparation, and Application: A Review. Foods 2023;12:896. Available from: https://doi.org/10.3390/foods12040896. DOI: https://doi.org/10.3390/foods12040896
117. Auwal SM, Ghanisma SBM, Saari N. Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide. J Food Drug Anal 2024;32:358–70. Available from: https://doi.org/10.38212/2224-6614.3522. DOI: https://doi.org/10.38212/2224-6614.3522
118. Xiong W, Guo L, Zhang Y, Li S, Wu Z, Cai S. Identification of novel angiotensin I-converting enzyme inhibitory peptides from walnut (Juglans sigillata Dode) protein hydrolysates and their vascular endothelial protective properties: In silico and in vitro studies. Curr Res Food Sci 2025;11:101135. Available from: https://doi.org/10.1016/j.crfs.2025.101135. DOI: https://doi.org/10.1016/j.crfs.2025.101135
119. Liang Y, Zu XY, Zhao YN, Li YQ, Wang CY, Zhao XZ, et al. Research on the Synergistic Inhibition of Angiotensin-Converting Enzyme (ACE) by the Gastrointestinal Digestion Products of the ACE Inhibitory Peptide FPPDVA. J Agric Food Chem 2024;72:24463–75. Available from: https://doi.org/10.1021/acs.jafc.4c05518. DOI: https://doi.org/10.1021/acs.jafc.4c05518
120. Wu Q, Luo F, Wang XL, Lin Q, Liu GQ. Angiotensin I-converting enzyme inhibitory peptide: an emerging candidate for vascular dysfunction therapy. Crit Rev Biotechnol 2022;42:736–55. Available from: https://doi.org/10.1080/07388551.2021.1948816. DOI: https://doi.org/10.1080/07388551.2021.1948816
121. Zheng Y, Zhang Y, San S. Efficacy of a Novel ACE-Inhibitory Peptide from Sargassum Maclurei in Hypertension and Reduction of Intracellular Endothelin-1. Nutrients 2020;12:653. Available from: https://doi.org/10.3390/nu12030653. DOI: https://doi.org/10.3390/nu12030653
122. Ming L, Yi S, Chi L, Zheng H, Li Z, Deng Y, et al. Long-term antihypertensive effect of angiotensin-converting enzyme inhibitory peptide LAP. Kidney Blood Press Res 2011;34:358–64. Available from: https://doi.org/10.1159/000327849. DOI: https://doi.org/10.1159/000327849
123. Li K, Jiang P, Li S, Sun J, Qi C. ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial. Sci Rep 2025;15:13840. Available from: https://doi.org/10.1038/s41598-025-98446-6. DOI: https://doi.org/10.1038/s41598-025-98446-6
124. Hamming I, Navis G, Kocks MJA, van Goor H. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol 2006;209:129–39. Available from: https://doi.org/10.1002/path.1956. DOI: https://doi.org/10.1002/path.1956